Robert Perkins
Family Medicine · Philadelphia, PANPI 1366892416
Payments from drug & device makers
Across 132 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$868
- Novo Nordisk$197
- Bayer$188
- Boehringer Ingelheim$186
- Biohaven Pharmaceutical Holding Company Ltd.$148
- GSK$143
- plus $644 from 16 others
What the payments were for
- Food & beverage$2,366100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $868 |
| Novo Nordisk | 12 | $197 |
| Bayer | 9 | $188 |
| Boehringer Ingelheim | 9 | $186 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $148 |
| GSK | 8 | $143 |
| Lilly USA, LLC | 8 | $140 |
| Amgen | 9 | $140 |
| Pfizer | 4 | $80 |
| Agile Therapeutics, Inc. | 2 | $42 |
| Radius Health, Inc. | 2 | $33 |
| Vertex | 1 | $26 |
| Millicent US Inc | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Abbott | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Circassia Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$2,374 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 185 | $190,164 |
| OzempicSemaglutide | 88 | $118,658 |
| EliquisApixaban | 89 | $93,463 |
| TrulicityDulaglutide | 64 | $77,064 |
| FarxigaDapagliflozin Propanediol | 68 | $71,177 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $44,403 |
| XareltoRivaroxaban | 35 | $39,421 |
| RybelsusSemaglutide | 30 | $34,158 |
| JanuviaSitagliptin Phosphate | 28 | $32,155 |
| TradjentaLinagliptin | 28 | $18,230 |
| EntrestoSacubitril/Valsartan | 11 | $14,944 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $12,697 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 89 | $12,217 |
| LinzessLinaclotide | 13 | $12,011 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 118 | $10,919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $186 | $208,395213 claims |
| Novo NordiskOzempic, Rybelsus | $197 | $152,815118 claims |
| PfizerEliquis | $80 | $93,46389 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Seroquel | $13 | $89,260110 claims |
| Lilly USA, LLCTrulicity | $140 | $77,06464 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta | $143 | $61,28297 claims |
| AbbVieLinzess | $868 | $12,01113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Philadelphia
- Daniel LinPhiladelphia$392K
- Glenn RosenPhiladelphia$367K
- Christopher ChambersPhiladelphia$350K
- Deborah WittPhiladelphia$226K
- Michael AttanasioPhiladelphia$214K
- Jonah MinkPhiladelphia$145K
- Celia EzidiegwuPhiladelphia$118K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.